CoChat

Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data

Open access

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Background: Pancreatic cancer (PC) represents a substantial public health burden. Pancreatic cancer patients have very low survival due to the difficulty of identifying cancers early when the tumour is localised to the site of origin and treatable. Recent progress has been made in identifying biomarkers for PC in the blood and urine, but these cannot be used for population-based screening as this would be prohibitively expensive and potentially harmful. Methods: We conducted a case-control study using prospectively-collected electronic health records from primary care individually-linked to cancer registrations. Our cases were comprised of 1,139 patients, aged 15–99 years, diagnosed with pancreatic cancer between January 1, 2005 and June 30, 2009. Each case was age-, sex- and diagnosis time-matched to four non-pancreatic (cancer patient) controls. Disease and prescription codes for the 24 months prior to diagnosis were used to identify 57 individual symptoms. Using a machine learning approach, we trained a logistic regression model on 75% of the data to predict patients who later developed PC and tested the model’s performance on the remaining 25%. Results: We were able to identify 41.3% of patients < = 60 years at ‘high risk’ of developing pancreatic cancer up to 20 months prior to diagnosis with 72.5% sensitivity, 59% specificity and, 66% AUC. 43.2% of patients >60 years were similarly identified at 17 months, with 65% sensitivity, 57% specificity and, 61% AUC. We estimate that combining our algorithm with currently available biomarker tests could result in 30 older and 400 younger patients per cancer being identified as ‘potential patients’, and the earlier diagnosis of around 60% of tumours. Conclusion: After further work this approach could be applied in the primary care setting and has the potential to be used alongside a non-invasive biomarker test to increase earlier diagnosis. This would result in a greater number of patients surviving this devastating disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0251876

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Schematic of multi-stage screening process starting with machine-learning derived algorithm.
Fig 1 Schematic of multi-stage screening process starting with machine-learning derived algorithm.CC BY · PubMed Central
Fig 2 Model parameters obtained in each time window (0–24,1–24,…,20–24 months) prior to diagnosis. a) AUC (%) b) Sensitivity (%) c) Specificity (%).
Fig 2 Model parameters obtained in each time window (0–24,1–24,…,20–24 months) prior to diagnosis. a) AUC (%) b) Sensitivity (%) c) Specificity (%).CC BY · PubMed Central
Fig 3 AUC, sensitivity and specificity of the models with % of the population recommended for biomarker (Stage 2) testing.
Fig 3 AUC, sensitivity and specificity of the models with % of the population recommended for biomarker (Stage 2) testing.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 1

  1. 22. Team R. RStudio: Integrated Development for R. RStudio Boston, MA RStudio, PBC.; 2020 [Available from: http://www.rstudio.com/.

Cited by

Metadata

Authors
Malhotra, A., Rachet, B., Bonaventure, A., Pereira, S. P., & Woods, L. M.
Affiliations
  • London School of Hygiene & Tropical Medicine (GB)
  • Inserm (FR)
  • University College London (GB)
Corresponding author
Malhotra, Ananya
Venue
PLOS ONE
Published
2021-06-02
Volume
16
Issue
6
Pages
e0251876
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3164089558
Cited by
56
References
26
Citations by year
2026: 5 · 2025: 12 · 2024: 8 · 2023: 15 · 2022: 9 · 2021: 7
FWCI
3.55
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Pancreatic Cancer Research Fund
  • UCLH Biomedical Research Centre
  • Fondation ARC pour la Recherche sur le Cancer (PDF20190508759)
  • Cancer Research UK (C7923/A18525, C23409/A11415)
  • Department of Health's National Institute for Health Research Biomedical Research Centres
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
pancreatic cancer, cancer screening, early diagnosis, risk prediction, primary care, electronic health records, symptom-based prediction, logistic regression, non-invasive biomarkers, cancer registration, elderly patients
MeSH terms
Machine Learning, Adolescent, Adult, Aged, Aged, 80 and over, Algorithms, Female, Follow-Up Studies, Humans, Male, Middle Aged, Pancreatic Neoplasms, Primary Health Care, Prognosis, Prospective Studies, Survival Rate, Case-Control Studies, Risk Assessment, Early Detection of Cancer, Young Adult, Electronic Health Records

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.